Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
As the leadership vacuum at the top of the FDA looks poised to close with President Donald Trump’s nominee pick for a replacement commissioner, the agency is reportedly weighing whether to add two | As the leadership vacuum at the top of the FDA looks poised to close with President Donald Trump’s nominee pick for a replacement commissioner, the agency is reportedly weighing whether to add two new deputy posts under that role.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across…

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at…

The White House is reviewing finalists for FDA commissioner, suggesting the highly anticipated decision may come soon.

The agency is looking for way more than just a new commissioner.

The agency may not have permanent leadership until after the midterms, says one expert

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.